ACTIVE

APOTHEKER CHRIS VANHENTENRIJK, KLINISCHE BIOLOGIE

Financial year 2025 · Closed on 30/06/2025

Net result243,3 k €+43,6 %over 1 year

Gross margin353,9 k €+33,9 %over 1 year

Equity967,1 k €+33,6 %over 1 year

Identity

Source · BCE/KBO

APOTHEKER CHRIS VANHENTENRIJK, KLINISCHE BIOLOGIE is a Private limited company incorporated in 1995. Its registered office is in Herent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0455.664.923
Incorporation: 06/07/1995
Legal form: Private limited company
Registered office: Ganzemansberg 18
3020 Herent · FlandreSee on map
Contributed capital: 12 392,01 €
Latest accounts: 30/06/2025

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 16 financial years

	2025		2024		2023		2022		2018
Income statement
Gross margin	353,9 k €	+33.9%	264,4 k €	+28.4%	205,9 k €	+58.2%	130,1 k €	+65.0%	78,9 k €
EBITDA	350 k €	+34.4%	260,4 k €	+29.6%	201 k €	+60.6%	125,1 k €	+69.0%	74 k €
Operating result	317,2 k €	+34.8%	235,3 k €	+30.3%	180,6 k €	+71.1%	105,6 k €	+112%	49,9 k €
Net result	243,3 k €	+43.6%	169,5 k €	+20.9%	140,1 k €	+127%	61,8 k €	-41.6%	105,9 k €
Balance sheet
Equity	967,1 k €	+33.6%	723,8 k €	+30.6%	554,3 k €	-10.5%	619,2 k €	-40.5%	1 M €
Total assets	1 M €	+32.4%	768,8 k €	-3.7%	798,3 k €	+25.6%	635,6 k €	-41.4%	1,1 M €
Cash	347,1 k €	+382%	72 k €	-77.3%	317,7 k €	+47.9%	214,8 k €	-53.6%	462,5 k €
Debts	50 k €	+14.0%	43,8 k €	-81.9%	242,1 k €	+1525%	14,9 k €	-67.3%	45,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period
Christiaan Julien Vanhentenrijk	Directorsince 02/08/1995Managersince 02/08/1995ended

Ended mandates

Director	Mandates in this company	Period
Chris Vanhentenrijk	Manager
Julien Vanhentenrijk Christiaan	DirectorManager

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/01/2026	31/01/2025	29/01/2024	31/01/2023	31/01/2022	21/01/2021
General meeting	31/12/2025	31/12/2024	30/12/2023	31/12/2022	31/12/2021	07/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	30/06/2025	31/12/2025	30/01/2026	Dutch	PDF
Micro model	30/06/2024	31/12/2024	31/01/2025	Dutch	PDF
Micro model	30/06/2023	30/12/2023	29/01/2024	Dutch	PDF
Abridged model	30/06/2022	31/12/2022	31/01/2023	Dutch	PDF
Abridged model	30/06/2021	31/12/2021	31/01/2022	Dutch	PDF
Abridged model	30/06/2020	07/12/2020	21/01/2021	Dutch	PDF
Abridged model	30/06/2019	02/12/2019	30/01/2020	Dutch	PDF
Micro model	30/06/2018	03/12/2018	31/01/2019	Dutch	PDF
Abridged model	30/06/2017	04/12/2017	31/01/2018	Dutch	PDF
Abridged model	30/06/2016	05/12/2016	31/01/2017	Dutch	PDF
Abridged model	30/06/2015	07/12/2015	21/01/2016	Dutch	PDF
Abridged model	30/06/2014	01/12/2014	19/01/2015	Dutch	PDF
Abridged model	30/06/2013	02/12/2013	14/02/2014	Dutch	PDF
Abridged model	30/06/2012	03/12/2012	18/02/2013	Dutch	PDF
Abridged model	30/06/2011	05/12/2011	14/02/2012	Dutch	PDF
Abridged model	30/06/2010	06/12/2010	01/02/2011	Dutch	PDF
Abridged model	30/06/2009	07/12/2009	09/02/2010	Dutch	PDF
Abridged model	30/06/2008	01/12/2008	31/01/2009	Dutch	PDF
Abridged model	30/06/2007	03/12/2007	30/01/2008	Dutch	PDF
Abridged model	30/06/2006	04/12/2006	30/01/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 2 ended

Active mandates

Director	Mandates in this company	Period
Christiaan Julien Vanhentenrijk	Directorsince 02/08/1995Managersince 02/08/1995ended

Ended mandates

Director	Mandates in this company	Period
Chris Vanhentenrijk	Manager
Julien Vanhentenrijk Christiaan	DirectorManager

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/02/2020
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares05/01/2015
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates19/10/2005
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings16 filings

Mandates

Christiaan Julien Vanhentenrijk

19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

Vanhentenrijk Chris

Ganzemansberg 18, 3020 Herent

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Ganzemansberg 18, 3020 HerentCurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00025709

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
APOTHEKER CHRIS VANHENTENRIJK, KLINISCHE BIOLOGIECurrent		CBE
Vanhentenrijk Chris	accounts 2022 → 2025	Accounts 2025 · 2026-00025709

Events

2025
Annual accounts 2025243,3 k €↑
2024
Annual accounts 2024169,5 k €↑
2023
Annual accounts 2023140,1 k €↑
2022
Annual accounts 202261,8 k €↓
2018
Annual accounts 2018105,9 k €↑
2017
Annual accounts 201765 k €↑
2016
Annual accounts 201628,7 k €↓
2015
Annual accounts 201543,1 k €↑
2014
Annual accounts 201425,7 k €↓
2013
Annual accounts 201380,8 k €↑
2012
Annual accounts 201224,5 k €↓
2011
Annual accounts 201133,7 k €↓
2010
Annual accounts 201047,6 k €↑
2009
Annual accounts 200913,6 k €↑
2008
Annual accounts 2008-27,3 k €↓
2007
Annual accounts 200722,1 k €
06/07/1995
IncorporationPrivate limited company

APOTHEKER CHRIS VANHENTENRIJK, KLINISCHE BIOLOGIE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events